KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) Share-based Compensation Growth (1y) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. Growth (1y) (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn 4.55%
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn 4.17%
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn 8.29%
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn -5.13%
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn -11.76%
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 4.31%
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn 60.00%
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn 1.39%
10 Gsk 88.34 Bn 83.66 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 29, 2026 4.17%
Dec 28, 2025 29.83%
Sep 28, 2025 17.63%
Jun 29, 2025 20.23%
Mar 30, 2025 -4.64%
Dec 29, 2024 33.71%
Sep 29, 2024 -0.34%
Jun 30, 2024 -10.73%
Mar 31, 2024 -1.31%
Dec 31, 2023 -18.35%
Apr 2, 2023 10.07%
Apr 3, 2022 -9.45%
Oct 3, 2021 1.17%
Jul 4, 2021 8.59%
Apr 4, 2021 16.73%
Jan 3, 2021 0.00%
Sep 27, 2020 4.49%
Jun 28, 2020 3.82%
Mar 29, 2020 1.94%
Dec 29, 2019 2.56%
Sep 29, 2019 1.24%
Jun 30, 2019 0.64%
Mar 31, 2019 -3.73%
Dec 30, 2018 -23.53%
Sep 30, 2018 2.54%
Jul 1, 2018 6.48%
Apr 1, 2018 17.03%
Dec 31, 2017 1.49%
Apr 2, 2017 11.71%
Apr 3, 2016 0.49%
Sep 27, 2015 -1.46%
Jun 28, 2015 11.57%
Mar 29, 2015 3.03%
Dec 28, 2014 1.39%
Sep 28, 2014 27.95%
Jun 29, 2014 5.68%
Mar 30, 2014 2.06%
Dec 29, 2013 -2.04%
Sep 29, 2013 10.27%
Jun 30, 2013 16.84%
Mar 31, 2013 12.14%
Dec 30, 2012 0.00%
Apr 1, 2012 13.82%
Apr 3, 2011 -3.18%
Oct 3, 2010 6.96%
Jul 4, 2010 -18.68%
Apr 4, 2010 -1.26%